The <scp>PRIPS</scp> study: screening battery for subjects at risk for <scp>P</scp>arkinson's disease
Daniela Berg(Christian-Albrechts-Universität zu Kiel), Heike Stockner(Innsbruck Medical University), H Huber(German Center for Neurodegenerative Diseases), Stefanie Lerche(German Center for Neurodegenerative Diseases), Karin Srulijes(German Center for Neurodegenerative Diseases), Jana Godau(Hertie Institute for Clinical Brain Research), Werner Poewe(University of Verona), Walter Maetzler(Centre Hospitalier Universitaire de Lille), Alexandra Gaenslen(German Center for Neurodegenerative Diseases), Inga Liepelt‐Scarfone(German Center for Neurodegenerative Diseases), Jochen Klenk(Universität Ulm), Stefanie Behnke(University Medical Center), Klaus Seppi(Innsbruck Medical University), Klaus Faßbender(Saarland University), Philipp Mahlknecht(University College London)
Cited by 125
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k